Clovis Oncology, Inc. carries a market capitalization of 13.19M, placing it among publicly traded companies globally.
| Market Cap | 13.19M |
| Enterprise Value | N/A |
Clovis Oncology, Inc.'s stock has declined approximately -94.90482% over the past 52 weeks. The 50-day moving average sits at 0.68, while the 200-day moving average is 1.27.
| Beta (5Y) | N/A |
| 52-Week Price Change | -94.90482% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 1.27 |
| Average Volume (20 Days) | N/A |